US9322822B2ActiveUtilityA1

Method for detecting asbestos

Assignee: KURODA AKIOPriority: Aug 12, 2011Filed: Aug 9, 2012Granted: Apr 26, 2016
Est. expiryAug 12, 2031(~5 yrs left)· nominal 20-yr term from priority
G01N 21/6458G01N 21/6428G01N 33/5308
69
PatentIndex Score
2
Cited by
17
References
5
Claims

Abstract

In order to provide a method for more efficiently, easily, and accurately detecting asbestos without changing the asbestos detection criterion of the phase-contrast microscope/electron microscope method as compared with the phase-contrast microscope/electron microscope method, a phase-contrast microscope and a fluorescence microscope are used in combination to detect asbestos contained in a test sample after the test sample is made contact with an asbestos-binding protein having a fluorescent label.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for detecting asbestos, comprising the steps of:
 a) contacting an asbestos-binding protein complex having a fluorescent label with a test substance; 
 b) detecting a fibrous substance contained in the test substance with use of a phase-contrast/fluorescence microscope in phase-contrast mode, the fibrous substance having a length of 5 μm or more, a width of less than 3 μm, and a length-width ratio of 3:1 or more; and 
 c) determining that the fibrous substance to which the asbestos-binding protein complex is bound is asbestos by detecting, with use of the phase-contrast/fluorescence microscope in fluorescence mode, the asbestos-binding protein complex bound to the fibrous substance detected in step b) based on the fluorescent label; and 
 wherein step b) and step c) are carried out without changing a visual field of the phase-contrast/fluorescence microscope, and 
 wherein the asbestos-binding protein complex comprises four biotin-modified H-NS 60-90  asbestos binding polypeptides and a fluorescently-labeled streptavidin, wherein each of the biotin-modified asbestos binding polypeptides has an amino acid sequence consisting of SEQ ID NO:8 and one biotin molecule at the C-terminus and wherein the biotin-modified asbestos polypeptides bind to the fluorescently-labeled streptavidin through a biotin-streptavidin interaction. 
 
     
     
       2. The method according to  claim 1 , wherein:
 the test substance is collected with use of a filter; 
 the contact between the asbestos-binding protein complex having a fluorescent label and the test substance in step a) occurs on the filter; 
 the method further comprises a transparency step of making the filter transparent by spraying an acetone vapor on the filter after the contacting step a); and wherein 
 step b) is carried out after the transparency step. 
 
     
     
       3. The method according to  claim 1 , wherein steps b) and c) are repeated at least one time. 
     
     
       4. The method according to  claim 2 , wherein:
 the asbestos-binding protein complex binding with the fibrous substance is maintained after the transparency step; and 
 the fluorescent label is one whose fluorescence can be detected by the phase-contrast/fluorescence microscope in fluorescence mode after the transparency step. 
 
     
     
       5. The method according to  claim 4 , wherein the fluorescent label is at least one fluorescent substance selected from the group consisting of Cy3, DyLight488, fluorescein, Alexa488, ATT0488, CF488A, DyLight550 and CF555.

Join the waitlist — get patent alerts

Track US9322822B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.